Gregory Butchko
University of Michigan
7 Papers
364 Citations
Gregory Butchko is an academic researcher from University of Michigan. The author has contributed to research in topics: Radioimmunotherapy & Breast cancer. The author has an hindex of 6, co-authored 7 publications. Previous affiliations of Gregory Butchko include Beckman Coulter.
Chat about Author
Papers
Radioimmunotherapy of B-Cell Lymphoma with [131I]Anti-B1 (Anti-CD20) Antibody
Mark S. Kaminski,Kenneth R. Zasadny,Isaac R. Francis,Adam W. Milik,Charles W. Ross,Scott D. Moon,Shelley M. Crawford,Jeanne M. Burgess,Neil A. Petry,Gregory Butchko,Stephan D. Glenn,Richard L. Wahl +11 more
TL;DR: Radioimmunotherapy with 131I-labeled B-cell-specific anti-CD20 monoclonal antibody in 10 patients with CD20-positive B- cell lymphomas in whom primary chemotherapy had failed is a promising new treatment for lymphoma.
656
Patent
Radioimmunotherapy of lymphoma using anti-CD20 antibodies
Mark S. Kaminski,Gregory Butchko,Stephan D. Glenn,Richard L. Wahl +3 more
- 10 Sep 1996
TL;DR: In this article, the authors described a method for the treatment of lymphoma by administration of a B cell-specific antibody, which can be obtained in a radiometric dose range that does not require hematopoietic stem cell replacement as an adjunct therapy.
132
Patent
Radioimmunotherapy of lymphoma using anti-CD20
Mark S. Kaminski,Gregory Butchko,Stephan D. Glenn,Richard L. Wahl +3 more
- 16 Sep 1993
TL;DR: In this article, the authors described a method for the administration of a B cell-specific antibody for the treatment of lymphoma using a radiometric dose range that does not require hematopoietic stem cell replacement as an adjunct therapy.
117
•Journal Article
High-Dose 90Y Mx-Diethylenetriaminepentaacetic Acid (DTPA)-BrE-3 and Autologous Hematopoietic Stem Cell Support (AHSCS) for the Treatment of Advanced Breast Cancer: A Phase I Trial
David M. Schrier,Salomon M. Stemmer,Timothy Johnson,Ravindra Kasliwal,James L. Lear,S. Matthes,Sharon Taffs,Christopher Dufton,Stephan D. Glenn,Gregory Butchko,Robert L. Ceriani,Douglas Rovira,Paul A. Bunn,Elizabeth J. Shpall,Scott I. Bearman,Malcom Purdy,Pablo J. Cagnoni,Roy B. Jones +17 more
TL;DR: This Phase I trial explores the use of high-dose 90Y conjugated to the antibreast cancer monoclonal antibody BrE-3 and autologous hematologic cell support in the treatment of women with stage four breast cancer.
60
Patent
Process and apparatus for removal of dna and viruses
Stephan D. Glenn,Gregory Butchko,Edward O'connell,Paulette Smariga +3 more
- 20 Jun 1991
TL;DR: In this article, a single filtration device (12) containing coated filter membranes (32, 38, 62, 68) and absolute pore filters (34, 36, 64, 66) is provided.
34